RWD102 The Real-World Effectiveness of Tixagevimab and Cilgavimab in Immunocompromised Patients: A Single Center Study in Taiwan
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.2819
https://www.valueinhealthjournal.com/article/S1098-3015(23)05949-1/fulltext
Title :
RWD102 The Real-World Effectiveness of Tixagevimab and Cilgavimab in Immunocompromised Patients: A Single Center Study in Taiwan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05949-1&doi=10.1016/j.jval.2023.09.2819
First page :
Section Title :
Open access? :
No
Section Order :
12153